These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 8487826)

  • 1. Cutaneous disease and drug reactions in HIV infection.
    Coopman SA; Johnson RA; Platt R; Stern RS
    N Engl J Med; 1993 Jun; 328(23):1670-4. PubMed ID: 8487826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
    Kuaban C; Bercion R; Koulla-Shiro S
    East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts.
    Goh BK; Chan RK; Sen P; Theng CT; Tan HH; Wu YJ; Paton NI
    Int J Dermatol; 2007 Jul; 46(7):695-9. PubMed ID: 17614796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
    Smith KJ; Skelton HG; Yeager J; Ledsky R; Ng TH; Wagner KF
    Clin Exp Dermatol; 1997 May; 22(3):118-23. PubMed ID: 9425690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone-free antituberculosis treatment in Yaounde, Cameroon.
    Kuaban C; Bercion R; Koula-Shiro S
    Cent Afr J Med; 1998 Feb; 44(2):34-7. PubMed ID: 9675969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of cutaneous drug eruptions in adult Nigerians with HIV/AIDS.
    Salami TA; Asalu AF; Samuel SO
    Niger Postgrad Med J; 2010 Jun; 17(2):160-3. PubMed ID: 20539333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
    Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH
    N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania.
    Dukes CS; Sugarman J; Cegielski JP; Lallinger GJ; Mwakyusa DH
    Trop Geogr Med; 1992 Oct; 44(4):308-11. PubMed ID: 1284179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group.
    Hirschtick RE; Glassroth J; Jordan MC; Wilcosky TC; Wallace JM; Kvale PA; Markowitz N; Rosen MJ; Mangura BT; Hopewell PC
    N Engl J Med; 1995 Sep; 333(13):845-51. PubMed ID: 7651475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical aspects and treatment outcome in HIV-associated pulmonary tuberculosis: an experience from a Thai referral centre.
    Hongthiamthong P; Riantawan P; Subhannachart P; Fuangtong P
    J Med Assoc Thai; 1994 Oct; 77(10):520-5. PubMed ID: 7745373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse cutaneous reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia.
    Roudier C; Caumes E; Rogeaux O; Bricaire F; Gentilini M
    Arch Dermatol; 1994 Nov; 130(11):1383-6. PubMed ID: 7979438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin manifestations of human immunodeficiency virus (HIV): Part 2. Noninfectious skin manifestations.
    Kurgis BS
    J Am Osteopath Assoc; 1993 Feb; 93(2):223-9. PubMed ID: 8432670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninfectious inflammatory skin diseases in HIV-infected individuals.
    Cockerell CJ
    Dermatol Clin; 1991 Jul; 9(3):531-41. PubMed ID: 1831413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous drug reactions associated with newer antiretroviral agents.
    Martins CR
    J Drugs Dermatol; 2006; 5(10):976-82. PubMed ID: 17373147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
    Kaplan JE; Hu DJ; Holmes KK; Jaffe HW; Masur H; De Cock KM
    Am J Trop Med Hyg; 1996 Jul; 55(1):1-11. PubMed ID: 8702012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular manifestations of HIV infection.
    Jabs DA
    Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous manifestations in HIV positive patients.
    Supanaranond W; Desakorn V; Sitakalin C; Naing N; Chirachankul P
    Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):171-6. PubMed ID: 11485081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV infection among patients in U.S. acute care hospitals. Strategies for the counseling and testing of the hospital patients. The Hospital HIV Surveillance Group.
    Janssen RS; St Louis ME; Satten GA; Critchley SE; Petersen LR; Stafford RS; Ward JW; Hanson DL; Olivo N; Schable CA
    N Engl J Med; 1992 Aug; 327(7):445-52. PubMed ID: 1625734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of wasting and opportunistic infections in HIV-infected patients in West Africa: a realistic and necessary strategy before antiretroviral treatment].
    Ledru é ; Sanou PT; Dembele M; Dahourou H; Zoubga A; Durand G
    Sante; 1999; 9(5):293-300. PubMed ID: 10657773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.